Reductive amination of an amino acid or of an amino acid derivat

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

560 24, 560 38, 560159, 560171, C07D20716

Patent

active

053876962

ABSTRACT:
N-substituted .alpha.-amino acids and dipeptides are valuable intermediate products for the production of inhibitors of the angiotensin converting enzyme (ACE); representatives are e.g. enalapril and ramipril. These compounds are prepared by means of hydrogenolytic conversion of a primary amine with a ketone with the addition of an organic or inorganic base; among the inorganic bases, basic aluminum oxide is preferred. The use of chiral organic bases favors the production of a diastereomer.

REFERENCES:
patent: 4474692 (1984-10-01), Oka et al.
Article entitled "Synthesis and Pharmacology of the Potent Angiotensin-Converting . . . " J. Med. Chem. (1985) 28, 1596-1602, American Chemical Society; Johnson, et al.
Chemistry Letters, pp. 1691-1694, (1988) The chemical society of Japan; Iwasaki et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Reductive amination of an amino acid or of an amino acid derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reductive amination of an amino acid or of an amino acid derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reductive amination of an amino acid or of an amino acid derivat will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1111517

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.